期刊文献+

结直肠癌中hMLH1和hMSH2表达的临床意义 被引量:2

Clinical significance of the expression of hMLH1 and hMSH2 in colorectal cancer
暂未订购
导出
摘要 目的:探讨结直肠癌中hMLH1和hMSH2蛋白的表达的临床意义。方法:对山东省沂南县人民医院2007年2月—2010年2月间符合中国人HNPCC诊断标准的15例结直肠癌患者及同时期40例散发性结直肠癌患者的结直肠癌组织标本进行hMLH1和hMSH2蛋白检测,并对其临床病理资料进行回顾性分析。结果:15例HNPCC患者发病年龄<50岁的4人。在结直肠癌发生的部位上,10发生在右半结肠,5例发生在左半结肠。病理类型上管状腺癌3例、黏液腺癌7例、混合癌5例。分化程度上高分化3例、中分化4例、低分化癌8例。HNPCC组中hMLH1/hMSH2蛋白阴性表达共9例,其中有8例癌灶位于右半结肠,7例病理为低分化。散发组中hMLH1/hMSH2蛋白阴性表达共6例。尚未发现hMLH1和hMSH2两种蛋白在同一病例中均为阴性表达者。结论:hMLH1和hMSH2的阴性表达与癌灶部位与病理分化高度相关;可作为HNPCC的临床初步筛查指标之一。 Objective: Explore the chinical significance of hMLH1 and hMSH2 protein expression in the colorectal cancer. Methods: Detect the hMLH1 and hMSH2 protein in 15 HNPCC patients' colorectal cancer tissues and 40 cases' colorectal cancer tissues who had sporradic colorec- tal cancer in February 2007 to February 2010; and reviewed the clinical and pathological data. Re. suits: In HNPCC group, 4 numbers onset age 〈50. On the tumor location ,10 occurrence in the right half colon, 5 occurrence are in the left half colon. In pathology tape, tubular adenocarcinoma is 3 cases, mucinous adenocarcinoma is 7 cases, and mixed carcinoma is 5 cases. And well-differenti- ated is 3 cases, moderately differentiated is 4 cases, poorly differentiated is 8 cases. The negative expression of hMLH1/hMSH2 in the HNPCC group is 9 cases. 8 occurrence in the right half colon, and poorly differentiated is 7 cases. The negative expression of in the sporradic colorectal cancer group is 6 cases. Conclusion: The negative expression of hMLH1 and hMSH2 protein have significant difference in the tumor position and the degree of pathological differentiation, and highly related with them; hMLH1 and hMSH2 protein can be used as a clinnical indicator in initial screening of the HNPCC.
出处 《中国现代普通外科进展》 CAS 2012年第5期370-373,共4页 Chinese Journal of Current Advances in General Surgery
关键词 结直肠肿瘤·错配修复基因·遗传性·筛查 Colorectal neoplasms .Mismatch repair gene,Hereditary nonpolyposis colorectal cancer,Screening
  • 相关文献

参考文献12

二级参考文献74

  • 1刘文志,金锋,王舒宝.遗传性非息肉病性大肠癌和普通遗传性大肠癌临床表型分析[J].中国肿瘤临床,2005,32(14):811-813. 被引量:5
  • 2Lamberti C,Mangold E,Pagenstecher C,et al.Frequency of hereditary non-polyposis colorectal cancer among unselected patients with colorectal cancer in Germany[J].Digestion,2006,74(1):58-67.
  • 3Syngal S,Fox EA,Eng C,et al.Sensitivity and specificity of clinical criteria for hereditary non-polyposis colorectal cancer associated mutations in MSH2 and MLH1[J].J Med Genet,2000,37(9):641-645.
  • 4Mareus VA,Madlensky L,Gryfe R,et al.Immunohistochemistry for hMLH1 and hMSH2:a practical test for DNA mismatch repair deficient tumors[J].Am J Surg Pathol,1999,23(10):1248-1255.
  • 5Liu T,Wahlbery S,Burek E,et al.Microsatellite instability as a predictor of a mutation in a DNA mismatch repair gene in familial coloreetal caneer[J].Genes Chromosomes Cancer,2000,27(1):17-25.
  • 6Debniak T,Kurzawski G,Gorski B,et al.Value of pedigree/ clinical data,immunohistochemistry and microsatellite instability analyses in reducing the cost of determining hMLH1 and hMSH2 gene mutations in patients with colorectal cancer[J].Eur J Cancer,2000,36(1):49-54.
  • 7Dieumegard B,Grandjouan S,Sabourin JC,et al.Extensive molecular screening for hereditary non-polyposis colorectal cancer[J].Br J Cancer,2000,82(4):871-880.
  • 8Ferlay J, Bray F, Pisani P, et al. GlOBOCAN 2000. Cancer incidence, mortality and prevalence worldwide. Version 1.0.IARC CancerBase No 5[R]. Lyon, France: IARC press, 2001
  • 9United Nations. World population prospects. The 2000 revision. Population division. Department of economic and social affairs[R]. New York: United Nations, 2001
  • 10American cancer society. Cancer Facts &amp; figures 2002[R].Atlanta, GA: American Cancer Society, Inc. 2002

共引文献120

同被引文献26

  • 1Zhang R, Qin W, Xu GL, et al. A meta--analysis of the prevalence of somatic mutations in the hMLH1 and hMSH2 genes in colorec- tal cancer[J]. Colorectal Dis, 2012, 14(3):e80-89.
  • 2Friedrichs K, Gluba S, Eidtmann H, et al. Over expression of p53 and prognosis in breast cancer[J]. Cancer, 1993, 72(12):3641--3647.
  • 3Fishel R, Lescoe MK, Rao MR, et al. The human mutator gene homolog MSH2 and its association with hereditary non polyposis colon cancer[J]. Cell,1993, 75(5):1027-1038.
  • 4Gammie AE, Erdeniz N, Beaver J, et al. Functional characterization of pathogenic human MSH2 missense mutations in saccharomyces cerevisiae[J]. Genetics, 2007, 177(2):707-721.
  • 5Sidelnikov E, Bostick RM, Flanders WD, et ai. Colorectal mucosal expression of MSH2 as a potential biomarker of risk for colorectal neoplasms[J]. Cancer Epidemiol Biomarkers Prey, 2009, 18(11): 2965--2973.
  • 6Seifert M, Reichrath J. The role of the human DNA mismatch re- pair gene hMSH2 in DNA repair, cell cycle control and apoptosis: implications for pathogenesis, progression and therapy of cancer[J]. J Mol Histol, 2006, 37( 5--7):301-307.
  • 7Gu M, Bae YK, Kim AR, et al. Expression of hMLH1, hMSH2 and hMSH6 in small intestinal carcinomas[J].Hepatogastroenterology, 2012, 59(119): 2228--2232.
  • 8Alkhalidi H, Kfoury H. Status of mismatch repair genes hMSH2 and hMSH6 in colorectal cancer in Saudi patients: an immunohisto- chemical analysis[J]. East Mediterr Health J, 2012, 18(11):1114-1117.
  • 9Koessler T, Azzato EM, Perkins B, et al. Gommon germ line variation in mismatch repair genes and survival after a diagnosis of colorectal cancer[J]. IntJ Gancer, 2009, 124(8):1887-1891.
  • 10宋伟庆,范占彬,王烨,袁虎方,杨彦林,王利伟,韩彩丽.散发性结直肠癌中hMSH2与PTEN的表达及临床意义[J].世界华人消化杂志,2008,16(19):2125-2130. 被引量:1

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部